Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation - Kim, Hyeyoung; Yi, Nam-Joon; Lee, Juyeun; Kim, Joohyun; Moon, Mi-Ra; Jeong, Jaehong; Lee, Jeong-Moo; You, Tae Suk; Suh, Suk-Won; Park, Min-Su; Choi, YoungRok; Hong, Geun; et al. (Clinical and molecular hepatology, 2014)
Keywords: Adult; Aged; Area Under Curve; Area under the curve; Biopsy; Blood; Creatinine; Drug dosages; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Diseases - etiology; Graft Rejection - prevention & control; Hepatitis B; Humans; Immunosuppressive Agents - blood; Immunosuppressive Agents - pharmacokinetics; Leukopenia - etiology; Liver - pathology; Liver cancer; Liver Failure - therapy; Liver transplant; Liver Transplantation; Liver transplants; Male; Middle Aged; Mycophenolate mofeti; Mycophenolic acid; Mycophenolic Acid - adverse effects; Mycophenolic Acid - analogs & derivatives; Mycophenolic Acid - blood; Mycophenolic Acid - pharmacokinetics; Original; Patients; Pharmacokinetics; Retrospective Studies; Review boards; ROC Curve; Tacrolimus - therapeutic use; Therapeutic drug monitoring; Tissue Donors; 내과학; Therapeutic drug monitoring; Liver transplant; Mycophenolate mofeti; Mycophenolic acid; Area under the curve